STK11 and neoplasm: In almost every mouse treated with selumetinib only, the TUNEL signal was significantly higher in the A549LKB1 tumor than its matched A549pBabe tumor, consistent with our observation that the loss of LKB1 confers resistance to selumetinib whereas the restoration of wild type LKB1 enhances sensitivity (Supplementary Figure 3D).